On March 8, 2023 Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, reported the company will participate in and be available for 1×1 meetings at the following upcoming conferences (Press release, Cellectar Biosciences, MAR 8, 2023, View Source [SID1234628328]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Roth Capital Partners 35th Annual Conference
Date: March 13, 2023
Time: 8:30 – 8:55 AM ET
Format: Fireside Chat and available for 1×1 investor meetings
Webcast: To register, click on the link HERE
Oppenheimer 33rd Annual Healthcare Conference
Date: March 14, 2023
Time: 10:00 – 10:30 AM ET
Format: Virtual presentation and available for 1×1 investor meetings
Webcast: To register, click on the link HERE
A replay of the Oppenheimer presentation will be available on the Events Page of the company website.